292 related articles for article (PubMed ID: 32269064)
1. Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.
Peschken CA
J Rheumatol; 2020 Jun; 47(6):787-790. PubMed ID: 32269064
[No Abstract] [Full Text] [Related]
2. Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.
Jakhar D; Kaur I
Nat Med; 2020 May; 26(5):632. PubMed ID: 32269358
[No Abstract] [Full Text] [Related]
3. Hydroxychloroquine: A Potential Ethical Dilemma for Rheumatologists during the COVID-19 Pandemic.
Scuccimarri R; Sutton E; Fitzcharles MA
J Rheumatol; 2020 Jun; 47(6):783-786. PubMed ID: 32241801
[No Abstract] [Full Text] [Related]
4. Regulators split on antimalarials for COVID-19.
Jaffe S
Lancet; 2020 Apr; 395(10231):1179. PubMed ID: 32278373
[No Abstract] [Full Text] [Related]
5. Impact of COVID-19 pandemic on SLE: beyond the risk of infection.
Horisberger A; Moi L; Ribi C; Comte D
Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32376774
[No Abstract] [Full Text] [Related]
6. Considerations of Managing Lichen Planopilaris With Hydroxychloroquine During the COVID-19 Pandemic.
Dadkhahfar S; Araghi F; Tabary M; Moravvej H
J Drugs Dermatol; 2020 Jun; 19(6):679-680. PubMed ID: 32574007
[No Abstract] [Full Text] [Related]
7. Does hydroxychloroquine combat COVID-19? A timeline of evidence.
Alia E; Grant-Kels JM
J Am Acad Dermatol; 2020 Jul; 83(1):e33-e34. PubMed ID: 32283236
[No Abstract] [Full Text] [Related]
8. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.
Konig MF; Kim AH; Scheetz MH; Graef ER; Liew JW; Simard J; Machado PM; Gianfrancesco M; Yazdany J; Langguth D; Robinson PC;
Ann Rheum Dis; 2020 Oct; 79(10):1386-1388. PubMed ID: 32381561
[No Abstract] [Full Text] [Related]
9. Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.
Yazdany J; Kim AHJ
Ann Intern Med; 2020 Jun; 172(11):754-755. PubMed ID: 32232419
[TBL] [Abstract][Full Text] [Related]
10. The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic.
Shah M; Sachdeva M; Dodiuk-Gad RP
Dermatol Ther; 2020 Jul; 33(4):e13524. PubMed ID: 32383251
[No Abstract] [Full Text] [Related]
11. Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.
Malviya A
Indian Heart J; 2020; 72(2):131-132. PubMed ID: 32534688
[No Abstract] [Full Text] [Related]
12. [Hazard of acquired long QT syndrome during coronavirus pandemic. Focus on hydroxychloroquine].
Tomcsányi J; Tomcsányi K
Orv Hetil; 2020 Apr; 161(17):689-691. PubMed ID: 32324363
[TBL] [Abstract][Full Text] [Related]
13. Association Between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient Prescribing.
Harrigan JJ; Hubbard RA; Thomas S; Riello RJ; Bange E; Mamtani M; Mamtani R
J Gen Intern Med; 2020 Sep; 35(9):2826-2828. PubMed ID: 32542496
[No Abstract] [Full Text] [Related]
14. A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance.
Ahn BY; Kang CK; Seo JD; Choe PG; Song SH; Park WB; Park SW; Kim NJ; Oh MD
J Korean Med Sci; 2020 Jun; 35(24):e231. PubMed ID: 32567262
[TBL] [Abstract][Full Text] [Related]
15. Update on antimalarials and systemic lupus erythematosus.
Ruiz-Irastorza G; Martín-Iglesias D; Soto-Peleteiro A
Curr Opin Rheumatol; 2020 Nov; 32(6):572-582. PubMed ID: 32890029
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and Depression.
Shader RI
Clin Ther; 2020 Jun; 42(6):962-963. PubMed ID: 32362345
[TBL] [Abstract][Full Text] [Related]
17. Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline.
Bugatti S; De Stefano L; Bobbio-Pallavicini F; Montecucco C
RMD Open; 2020 Oct; 6(3):. PubMed ID: 33087414
[No Abstract] [Full Text] [Related]
18. [Not Available].
Nau JY
Rev Med Suisse; 2020 Apr; 16(690):756-757. PubMed ID: 32301315
[No Abstract] [Full Text] [Related]
19. [Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic?].
Defoort-Dhellemmes S
J Fr Ophtalmol; 2020 Jun; 43(6):548-549. PubMed ID: 32451138
[No Abstract] [Full Text] [Related]
20. [Not Available].
Nau JY
Rev Med Suisse; 2020 Apr; 16(689):704-705. PubMed ID: 32270942
[No Abstract] [Full Text] [Related]
[Next] [New Search]
